首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >Synthesis and structural investigation of some pyrimido(5,4-c)quinolin-4(3H)-one derivatives with a long-chain arylpiperazine moiety as potent 5-HT(1A/2A) and 5-HT(7) receptor ligands.
【24h】

Synthesis and structural investigation of some pyrimido(5,4-c)quinolin-4(3H)-one derivatives with a long-chain arylpiperazine moiety as potent 5-HT(1A/2A) and 5-HT(7) receptor ligands.

机译:具有长链芳基哌嗪部分作为有效的5-HT(1A / 2A)和5-HT(7)受体配体的一些嘧啶基(5,4-c)喹啉-4(3H)-one衍生物的合成和结构研究。

获取原文
获取原文并翻译 | 示例
           

摘要

A series of new pyrimido[5,4-c]quinolin-4(3H)-ones with variable length of the spacer between amide and 4-arylpiperazine moiety were prepared to further explore the role of a terminal portion in the serotonergic activity. The majority of compounds demonstrated high in vitro affinity for 5-HT(1A) receptor, and moderate-to-low affinity for 5-HT(2A) and 5-HT(7) receptors. X-ray analysis, two-dimensional NMR, conformational studies and docking into the 5-HT(1A) receptor model were conducted to investigate conformational preferences of selected 5-HT(1A) receptor ligands in different environments. The extended conformation of tetramethylene derivatives was found in a solid state, in DMSO (for a protonated form) and as a global energy minimum during conformational analysis in simulated water environment. Ligand geometry in top-scored complexes, obtained by docking to a set of 100 receptor models, were either fully extended or with central spacer torsion in synclinal conformation.
机译:制备一系列新的嘧啶并[5,4-c]喹啉-4(3H)-具有在酰胺和4-芳基哌嗪部分之间的间隔物的可变长度,以进一步探索末端部分在血清素能活性中的作用。大多数化合物对5-HT(1A)受体具有较高的体外亲和力,对5-HT(2A)和5-HT(7)受体具有中等至低的亲和力。进行了X射线分析,二维核磁共振,构象研究和对接到5-HT(1A)受体模型,以调查在不同环境中所选5-HT(1A)受体配体的构象偏好。在固态,DMSO(质子化形式)中发现了四亚甲基衍生物的扩展构象,并且在模拟水环境中进行构象分析时发现其总体能量最小值。通过对接至一组100个受体模型获得的得分最高的复合物中的配体几何形状完全延伸,或在向斜构象中带有中心间隔物扭转。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号